MSB 1.03% 98.0¢ mesoblast limited

Thanks for sharing@Wilba32I think it important to also reference...

  1. 535 Posts.
    lightbulb Created with Sketch. 140
    Thanks for sharing@Wilba32

    I think it important to also reference Dr Lightner's response to Dr Cheng's letter to the editor re the important role of anti-TNF in treating refractory pCD, suggesting a contributing role of MSCs....

    From Dr Lightner's reply
    "however, by definition, the patients enrolled were refractory to anti-TNF, and their fistulas had not healed despite being on medical therapy. In fact, all patients enrolled had either failed medical therapy or were on stable medical therapy for at least 3 months before study enrollment to minimize any
    confounding with MSC healing."

    Good signs but more work to do

    DYOR

    V




    Reference:
    https://hotcopper.com.au/data/attachments/6130/6130813-fffc85b353415c0e2be642c8ba462686.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
0.010(1.03%)
Mkt cap ! $1.118B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $5.286M 5.409M

Buyers (Bids)

No. Vol. Price($)
3 91218 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 63577 4
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.